QVC Group Extends 2025 Financial Results Release Date

BenzingaBenzinga
|||1 min read
Key Takeaway

QVC Group extended its 2025 financial results release deadline beyond February 26, 2026, citing need for additional audit and consolidation time. No accounting issues indicated.

QVC Group Extends 2025 Financial Results Release Date

QVC Group, Inc. announced a revision to its reporting timeline for fourth quarter and full-year 2025 financial results. The company has extended its disclosure deadline beyond the originally scheduled February 26, 2026 release date, now targeting completion within the extended filing window available to non-accelerated filers under Securities and Exchange Commission regulations.

The retailer, which operates a diversified portfolio spanning six brands including QVC and HSN as well as specialty home furnishing retailers Ballard Designs, Frontgate, Garnet Hill, and Grandin Road, cited the need for additional time to finalize its year-end audit and financial consolidation processes. The revised timeline aligns with SEC provisions that permit non-accelerated filers up to 90 days following fiscal year-end to file annual reports.

The postponement does not indicate any material accounting issues or concerns, as companies routinely utilize extended filing periods to ensure comprehensive financial reporting and regulatory compliance.

Source: Benzinga

Back to newsPublished Feb 20

Related Coverage

GlobeNewswire Inc.

Sika AG Shareholders Approve Board, Boost Dividend to CHF 3.70 Per Share

Sika AG shareholders approved CHF 3.70 dividend and board re-election at 2026 AGM, with company reporting CHF 11.20B sales and 33,700 employees globally.

SXYAY
GlobeNewswire Inc.

17EdTech Posts Narrower Loss Despite Revenue Decline as AI Product Gains Traction

17EdTech reports Q4 revenue growth of 6.4% YoY and significant margin expansion, though full-year revenues declined 44% due to business model shift. New AI product 'Yiqi Aixue' shows strong pre-sale demand.

YQ
The Motley Fool

Slide Insurance Posts $444M Profit on Strong Revenue Growth; Insider Trims Position

Slide Insurance reported $444M net income and $1.16B revenue, up 36% YoY. Director sold $1M in shares via pre-arranged plan while maintaining substantial stake.

SLDE
GlobeNewswire Inc.

IMUNON Sets March 31 Call to Detail 2025 Results, OVATION 3 Trial Progress

$IMNN to discuss 2025 results and OVATION 3 Phase 3 trial progress for IMNN-001 ovarian cancer immunotherapy on March 31, 2026.

IMNN
GlobeNewswire Inc.

Inventiva to Report 2025 Results as MASH Drug Candidate Advances

Inventiva will release 2025 financial results March 30, 2026, while advancing lanifibranor in Phase 3 MASH trials.

IVA
GlobeNewswire Inc.

Inventiva to Report 2025 Results as MASH Drug Candidate Advances in Phase 3

Inventiva to release 2025 financial results March 30, 2026, as its lanifibranor MASH drug advances through Phase 3 clinical trials.

IVA